Key Points
- Insider sale: Director Phyllis Gotlib sold 3,706 AMWL shares on April 1 at an average of $5.30 (~$19,642), reducing her holdings by 2.22% to 163,004 shares (SEC filing).
- Company outlook: Amwell remains loss-making despite a quarter that slightly beat EPS and revenue estimates; shares trade around $5.50 with a ~$91M market cap, and analysts mostly rate the stock "Hold" with an average target of $7.42 following several price cuts.
American Well Corporation (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 3,706 shares of the company's stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $5.30, for a total value of $19,641.80. Following the sale, the insider owned 163,004 shares of the company's stock, valued at approximately $863,921.20. This trade represents a 2.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Phyllis Gotlib also recently made the following trade(s):
- On Friday, January 2nd, Phyllis Gotlib sold 3,707 shares of American Well stock. The stock was sold at an average price of $4.85, for a total value of $17,978.95.
American Well Stock Up 4.1%
Shares of American Well stock opened at $5.51 on Friday. American Well Corporation has a 12-month low of $3.71 and a 12-month high of $9.15. The stock has a market capitalization of $91.11 million, a P/E ratio of -0.93 and a beta of 1.39. The stock has a 50 day moving average price of $5.22 and a two-hundred day moving average price of $5.09.
American Well (NYSE:AMWL - Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) earnings per share for the quarter, topping analysts' consensus estimates of ($1.59) by $0.07. American Well had a negative net margin of 38.38% and a negative return on equity of 35.33%. The business had revenue of $55.31 million during the quarter, compared to analysts' expectations of $52.71 million. Sell-side analysts anticipate that American Well Corporation will post -9.34 earnings per share for the current year.
Analysts Set New Price Targets
A number of analysts recently weighed in on AMWL shares. Stifel Nicolaus lowered their target price on shares of American Well from $6.00 to $5.00 and set a "hold" rating on the stock in a research note on Friday, February 13th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of American Well in a report on Wednesday, January 21st. Morgan Stanley lowered their price objective on American Well from $10.50 to $6.00 and set an "equal weight" rating on the stock in a research note on Thursday, December 18th. Finally, Wall Street Zen raised American Well from a "sell" rating to a "hold" rating in a report on Sunday, March 22nd. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $7.42.
Read Our Latest Stock Analysis on AMWL
Institutional Trading of American Well
Several hedge funds have recently modified their holdings of the stock. Headlands Technologies LLC acquired a new stake in shares of American Well in the second quarter valued at approximately $39,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in American Well during the 3rd quarter worth $62,000. Engineers Gate Manager LP bought a new position in American Well in the 2nd quarter valued at $101,000. Prelude Capital Management LLC bought a new position in American Well in the 3rd quarter valued at $86,000. Finally, JPMorgan Chase & Co. increased its stake in shares of American Well by 16.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company's stock valued at $131,000 after buying an additional 2,081 shares during the period. 56.05% of the stock is owned by institutional investors.
About American Well
(
Get Free Report)
American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.
The company's core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
